arbor pharmaceuticals, LLC

80 state street
albany, new york 12207

NYS Entity Status
ACTIVE

NYS Filing Date
DECEMBER 09, 2013

NYS DOS ID#
4498602

County
ALBANY

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2013 - ARBOR PHARMA LLC
2013 - ARBOR PHARMACEUTICALS, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
    Monday Oct 16, 2017

    Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.

    Source: The Wall Street Journal: U.S. Business
  • Inside a Secretive Group Where Women Are Branded
    By BARRY MEIER - Wednesday Oct 18, 2017

    A self-help organization in Albany called Nxivm has begun to unravel as members reveal disturbing practices and fears of blackmail.

    Source: NYT > Home Page
  • The Strange Case of Martin Shkreli Is Wrapping Up
    By STEPHANIE CLIFFORD - Wednesday Jul 26, 2017

    An unusual trial has featured victims who actually made money and defense lawyers who paint their client as an erratic misfit and want more victims to testify.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Phrixus to Launch Clinical Trials for Duchenne Drug in Early 2018
    By Sarah Schmid Stevenson - Monday Oct 16, 2017

    After showing some early promise in treating European patients, Ann Arbor, MI-based Phrixus Pharmaceuticals, a startup developing drugs to treat cardiac and respiratory problems in young males with Duchenne muscular dystrophy, is preparing to launch U.S. clinical trials early next year. During the first quarter of 2018, Phrixus will dose the first patient with its […]

    Source: Xconomy VC, Deals, & Startups Feed